PRIME-Cancer Research Program Mentors

PRIME Research Preceptors

Research Focus

Research Type

Benjamin Alman, MD

New drug therapies for musculoskeletal tumors

Translational

Andrew Armstrong, MD

Novel therapies and drug development for prostate, renal, bladder, and testicular cancer

Clinical

Gerard Blobe, MD, PhD

Role of TGF-├č superfamily signal transduction pathways in cancer biology

Basic

Michael Boyce, PhD

Protein glycosylation in mammalian health and disease

Basic

Jen-Tsan Ashley Chi, MD, PhD

Nutrient signaling and stress adaptations of cancer cells

Basic

Christopher Counter, PhD

Molecular mechanisms underlying the development of cancer

Basic

Anna Mae Diehl, MD

Liver injury and repair, including regulated cell death and regeneration

Basic

Donald Fox, PhD

Extreme genome variation in organ development and repair

Basic

Jennifer Freedman, PhD

Cancer disparities

Translational

Katherine Garman, MD

Cancer development in the gastrointestinal tract

Translational

Sarah Goetz, PhD

Molecular pathways and roles of cilia in cancer

Basic

Brent Hanks, MD, PhD

Molecular and cellular mechanisms involved in tumor-mediated immune suppression and cancer immunotherapy resistance

Basic/ Translational

Zachary Hartman, PhD

Immunity and inflammation in the context of cancer

Basic/ Translational

Jiaoti Huang, MD, PhD

Carcinogenesis, biomarkers, diagnosis, and novel therapeutic strategies of prostate cancer

Translational

Chuan-Yuan Li, DSc

Mechanisms of skin cancer carcinogenesis; melanoma and squamous cell carcinoma response to therapy; stem cell and regenerative therapy

Basic/ Translational

Corinne Linardic, MD

Signaling pathways in rhabdomyosarcoma

Basic

Micah Luftig, PhD

Pathogenesis of viruses that cause cancer

Basic

Donald McDonnell, PhD

Identification of novel therapeutics for hormonally responsive cancers

Basic/ Translational/ Clinical

Steven Patierno, PhD

Molecular biology of cancer disparities; targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness

Translational

Ann Marie Pendergast, PhD

Tyrosine kinase-regulated transcription networks in tumor progression to metastasis

Basic

Nirmala Ramanujam, PhD

Technology innovations for cancer surveillance

Translational

Stefanie Sarantopoulos, MD, PhD

Immunotherapies for leukemia and lymphoma; stem cell therapy

Translational

David Sherwood, PhD

Cell invasion, stem cell regulation, and cell-matrix interactions in cancer

Basic

Dorothy Sipkins, MD, PhD

Blocking breast cancer relapse

Translational/ Clinical

Joshua Snyder, PhD

Cancer cell adaptation and growth before diagnosis

Basic/ Translational

Jason Somarelli, PhD

Evolution of cancer drug resistance and metastasis

Translational

Beth Sullivan, PhD

Chromosome abnormalities associated with cancer

Basic

Kyle Walsh, PhD

Telomere maintenance in pre-malignant cells and development of glioblastoma

Basic

Xiao Fan Wang, PhD

Tumor microenvironment changes that impact progression and metastasis

Basic

Kris Wood, PhD

Principles underlying the design of new, durable anticancer therapeutic strategies

Translational

Jennifer Zhang, PhD

Gene regulation of epithelial cell proliferation; keratinocytes as instigators of inflammatory responses; ubiquitination enzymes in melanoma

Basic